Research.Patient.info

Treatment of X-linked Chronic Granulomatous Disease research hub

1 indexed studies · 0 currently recruiting

ongoing, recruitingPhase I and Phase II (Integrated)- First administration to humans
A phase I/II, non randomized, monocentric open-label study of autologous CD34+ cells transduced with the G1XCGD lentiviral vector in patients with X-linked chronic granulomatous disease
This study is testing a new gene therapy for X-linked Chronic Granulomatous Disease (X-CGD), a rare immune disorder. It uses a patient's own cells, modified in the lab, to help their immune system work better. Researchers are checking if it's safe and helps improve the body's ability to fight infections.
France